Aravax Investors
Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.
Headquarters:
Melbourne, Victoria, Australia
Employee Number:
11-50
Industry:
PharmTech
Founded Date:
2015